Showing results (71-80 of 106) with videos related to
Sort By:
Pageof 11
European Journal of Immunology|March 1, 2002
NK cells developing in vitro from fetal mouse progenitors express at least one member of the Ly49 family that is acquired in a time-dependent and stochastic manner independently of CD94 and NKG2Karen P Fraser, Frances Gays, John H Robinson, et al.Science (New York, N.Y.)|March 7, 2015
Antitumor immunity. A shed NKG2D ligand that promotes natural killer cell activation and tumor rejectionWeiwen Deng, Benjamin G Gowen, Li Zhang, et al.Science Advances|December 10, 2020
Millikelvin-resolved ambient thermographyKechao Tang, Kaichen Dong, Christopher J Nicolai, et al.Elife|December 13, 2017
Endothelial cells express NKG2D ligands and desensitize antitumor NK responsesThornton W Thompson, Alexander Byungsuk Kim, P Jonathan Li, et al.Elife|May 15, 2018
Tumor-derived CSF-1 induces the NKG2D ligand RAE-1δ on tumor-infiltrating macrophagesThornton W Thompson, Benjamin T Jackson, P Jonathan Li, et al.Journal of Immunology (Baltimore, Md. : 1950)|February 23, 2010
Endoplasmic reticulum aminopeptidase associated with antigen processing defines the composition and structure of MHC class I peptide repertoire in normal and virus-infected cellsNicolas Blanchard, Takayuki Kanaseki, Hernando Escobar, et al.Elife|November 23, 2016
A Herpesviral induction of RAE-1 NKG2D ligand expression occurs through release of HDAC mediated repressionTrever T Greene, Maria Tokuyama, Giselle M Knudsen, et al.Blood|March 20, 2015
NKG2D expression by CD8+ T cells contributes to GVHD and GVT effects in a murine model of allogeneic HSCTMobin A Karimi, Jerrod L Bryson, Lee P Richman, et al.The Journal of Clinical Investigation|October 21, 2014
Cytokine therapy reverses NK cell anergy in MHC-deficient tumorsMichele Ardolino, Camillia S Azimi, Alexandre Iannello, et al.Cancer Cell|June 15, 2021
Innate immune cells in the tumor microenvironmentMing O Li, Natalie Wolf, David H Raulet, et al.Pageof 11